MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pariante, C. M.
Right arrow Articles by Miller, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pariante, C. M.
Right arrow Articles by Miller, A. H.

0026-895X/97/040571-11$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:571-581 (1997).

Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine

Carmine M. Pariante,1 Bradley D. Pearce, Tracy L. Pisell, Michael J. Owens, and Andrew H. Miller

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322

The glucocorticoid receptor (GR) is a ligand-regulated transcription factor that in its unactivated form resides primarily in the cytoplasm. After being bound by steroid, the GR undergoes a conformational change and translocates to the nucleus, where it influences gene transcription. Because the GR mediates negative feedback exerted by circulating glucocorticoid hormones on the hypothalamic-pituitary-adrenal (HPA) axis, it has been hypothesized that abnormalities in GR expression and/or function may underlie the HPA axis hyperactivity described in patients with major depression. In further support of this hypothesis, animal studies have shown that long term in vivo treatment with antidepressants enhances glucocorticoid feedback inhibition, possibly through a direct effect on the GR. To examine this latter possibility, we evaluated translocation of the GR from the cytoplasm to the nucleus after 24-hr in vitro treatment of L929 cells (mouse fibroblasts) with the tricyclic antidepressant desipramine (0.1-10 µM) in the presence or absence of the synthetic steroid dexamethasone. In addition, GR-mediated gene transcription was measured with the use of L929 cells stably transfected with the mouse mammary tumor virus-chloramphenicol acetyltransferase reporter gene. Desipramine was found to (i) induce GR translocation from the cytoplasm to the nucleus in the absence of steroids (with no effect alone on GR-mediated gene transcription) and (ii) potentiate dexamethasone-induced GR translocation and dexamethasone-induced GR-mediated gene transcription. Treatment with desipramine for 24-96 hr had no effect on the expression of GR protein as measured by cytosolic radioligand receptor binding. We suggest that one important aspect of the effects of antidepressants in vivo may be to facilitate GR-mediated feedback inhibition on the HPA axis, by facilitating GR translocation and function, and thereby reverse glucocorticoid hypersecretion in depression.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. M. Pariante
The glucocorticoid receptor: part of the solution or part of the problem?
J Psychopharmacol, July 1, 2006; 20(4 Suppl): 79 - 84.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C. Maddock, A. Baita, M. G. Orru, R. Sitzia, A. Costa, E. Muntoni, M. G. Farci, B. Carpiniello, and C. M. Pariante
Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-{alpha}: a Prospective Case Series and a Discussion of Biological Mechanisms
J Psychopharmacol, March 1, 2004; 18(1): 41 - 46.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
C. L. Raison and A. H. Miller
When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders
Am J Psychiatry, September 1, 2003; 160(9): 1554 - 1565.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Lyu, J.-A Kim, S. K. Chung, K.-S. Kim, and C.-K. Joo
Alteration of Cadherin in Dexamethasone-Induced Cataract Organ-Cultured Rat Lens
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2034 - 2040.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. McQUADE and A. H. Y. YOUNG
Future therapeutic targets in mood disorders: the glucocorticoid receptor
The British Journal of Psychiatry, November 1, 2000; 177(5): 390 - 395.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Pariante, B. D. Pearce, T. L. Pisell, C. I. Sanchez, C. Po, C. Su, and A. H. Miller
The Proinflammatory Cytokine, Interleukin-1{alpha}, Reduces Glucocorticoid Receptor Translocation and Function
Endocrinology, September 1, 1999; 140(9): 4359 - 4366.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Okamoto, H. Tanaka, H. Ogawa, Y. Makino, H. Eguchi, S.-i. Hayashi, N. Yoshikawa, L. Poellinger, K. Umesono, and I. Makino
Redox-dependent Regulation of Nuclear Import of the Glucocorticoid Receptor
J. Biol. Chem., April 9, 1999; 274(15): 10363 - 10371.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics